Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Oral Treprostinil for the Treatment of Pulmonary Arterial Hypertension in Patients Receiving Background Endothelin Receptor Antagonist and Phosphodiesterase Type 5 Inhibitor Therapy (The FREEDOM-C2 Study)
PaperCitations, authors & open-access status
Oral Treprostinil for the Treatment of Pulmonary Arterial Hypertension in Patients Receiving Background Endothelin Receptor Antagonist and Phosphodiesterase Type 5 Inhibitor Therapy (The FREEDOM-C2 Study) is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 294 citations, 2013 year and closed oa status.
294
Citations
2013
Year
closed
OA Status